Federal Agency Halts Studies of Hydroxychloroquine, Drug Trump Promoted
The National Institutes of Health said Saturday that it had stopped two clinical trials of hydroxychloroquine, the malaria drug that President Trump promoted to treat and prevent the coronavirus, one because the drug was unlikely to be effective and the other because not enough patients signed up to participate. The agency halted a trial that… Read More »
